Back to the main directory
EarningsReview / Equity
- Espresso | Sodexo | Hold | The end of the tunnel? by Kepler Cheuvreux
- Incorporating capex delays by key customers by BNP Paribas Exane
- Estimates and Target Price revised due to GIMA TT by BNP Paribas Exane
- Reassuring Q3 results and outlook by BNP Paribas Exane
- 360 Report | M1 Kliniken | Buy | Untouched beauty by Kepler Cheuvreux
- Investment Daily 02/11/2018 by BNP Paribas Exane
- Subsea 7 (Hold, TP: NOK120.00) - Lost year(s) ahead by DnB Markets
- 360 Report | Inventiva | Buy | Data is coming! by Kepler Cheuvreux
- TGS Nopec (Hold, TP: NOK287.00) - Still-high risk on 2019 consensus by DnB Markets
- CRC: Newsom Will Be CA's Next Governor, but Whether CalRe Will Have FCF in 2019 Is Still Debatable by Raymond James
- WOOD Flash – MMK: 3Q18 financial results – 5% ahead of consensus EBITDA, 4.4% quarterly dividend yield by Wood and Company
- NE: Jackups Well Contracted, Seeing Opportunities to Add Rigs by Raymond James
- Dorian LPG (Hold, TP: USD8.50) - Entering low season by DnB Markets
- SRCL: 3Q Performance Mixed as CRS Business Takes Down Guidance Again by Raymond James
- SYMC: F2Q Results Encouraging; FY19/20 Guide Reiterated; Market Perform by Raymond James
- ANET: 3Q18 Results: The Clouds Have Not Cleared and That's a Good Thing, Estimates Increase by Raymond James
- LADR: Gains Drive 3Q Beat; Increases Regular Dividend and Announces Special; Reiterate Strong Buy by Raymond James
- AR: Market Shrugs Off Higher 3Q Spending; Focused on Pending Buybacks by Raymond James
- ALK-Abello (Hold, TP: DKK1175.00) - Do not expect a repeat of Q2 by DnB Markets
- EGOV: Adios Texas, NIC Has an Encouraging Road Ahead by Raymond James
- WELL: Attention SHOP-ers; Reiterate Outperform Rating, Target Price to $72 (+$6) by Raymond James
- CBOE: 3Q18: Favorable Environment to Close Out 2018; Raising Target to $117 by Raymond James
- TRMB: Solid 3Q Results and 2019 Outlook Steady the Stock by Raymond James
- CI: Publishing Model Update by Raymond James
- Lundbeck (Hold, TP: DKK310.00) - Looking for a guidance upgrade by DnB Markets
- INAP: Making Sense of the Reaction to Guidance by Raymond James
- Slim returns (+25 questions on SlimFast) by BNP Paribas Exane
- Back on Track by BNP Paribas Exane
- Coloplast (Buy, TP: DKK700.00) - 2018/19 another investment year by DnB Markets
- 2,052 scrubbers so far by DnB Markets
- ADVM: Downgrading to Market Perform – ADVM-043 No Longer ADVANCE-ing by Raymond James
- WCC: Updating Model Post-3Q; WCC Executing Well Amid Slightly Soft Sales by Raymond James
- CTRL: Solid Q3; Margin Trends Suggests No Evidence of Commoditization; Maintain Outperform by Raymond James
- MD: Shares Fall on 4Q Outlook; Valuation Starting to Look More Compelling by Raymond James
- TUSK: Oilfield Softening but Infrastructure Margins Provide Buffer by Raymond James
- HTGC: Covers Dividend, Appealing Originations Uncertain; Maintain MP3 by Raymond James
- UNIT: Continued Diversification Underscores Model Momentum by Raymond James
- MSI: 3Q: Few Surprises; Path to Improved Mix and Returns Intact; Outperform by Raymond James
- PGTI: Solid 3Q18 Beats Views, Tough Comparisons and Tariffs Ahead by Raymond James
- FATE: 3Q18 Update: Flush With Cash – Readouts at SITC and ASH by Raymond James
- TPX: Reaffirm Strong Buy & $60 Target Price Following 3Q18 Results by Raymond James
- FTNT: 3Q Beat & Raise: Enterprise and Fabric Traction Continues; Market Perform by Raymond James
- CNXN: 3Q Results in Line With Preannouncement; Maintain Market Perform by Raymond James
- Golar LNG (Buy, TP: USD43.00) - The spot vessels strike back by DnB Markets
- No major surprise expected but keep an eye on the debt by BNP Paribas Exane
- In The Waiting Room - 3Q18 Prep by BNP Paribas Exane
- NPTN: 3Q18 Report: Favorable Trends, Limited Profitability, Maintain Market Perform by Raymond James
- Loomis (Buy, TP: SEK385.00) - Back on track in France by DnB Markets
- CVX: Even With Today's Gain, CVX No Longer a Crowded Trade; Buyback Boost Could Be Just the Ticket by Raymond James
- HFBC: Maintain Market Perform, Adjusting EPS Following 3Q18 Results by Raymond James